Silo Pharma Inc. (SILO)
NASDAQ: SILOHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
SILO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.98M
- EPS (TTM)
- -$4.26
- Dividend yield
- None
- 52-week range
- 1.30 – 10.44
- Day range
- 1.37 – 1.45
- Volume / Avg
- 14.29K / 114.43K
- Beta
- —
- Shares outstanding
- 2.05M
52-week range
SILO stock today
Shares of Silo Pharma (SILO) finished higher on Oct 8 at $1.45, a gain of 0.69% or $0.01 per share, versus the S&P 500's 0.47% decline. Trading was light, with 14.29K shares changing hands, about 12% of the average daily volume. Shares are 86.1% below their 52-week high of $10.44 and 11.5% above the 52-week low of $1.30, near the bottom of the past year's range.
Silo Pharma has posted a net loss over the last twelve months (EPS of -$4.26), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Silo Pharma
Company profileSilo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Eric Weisblum
- Headquarters
- Sarasota, FL
- Employees
- 3
- Website
- silopharma.com
Silo Pharma peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VIVSVivoSim Labs Inc. | 0.1772 | -7.47% | $2.94M | vs SILO |
| MLECMoolec Science SA | 4.19 | -12.89% | $3.04M | vs SILO |
| GOVXGeoVax Labs Inc. | 0.2866 | -0.97% | $2.90M | vs SILO |
| REVBRevelation Biosciences Inc. | 0.7739 | -6.55% | $3.08M | vs SILO |
| MBIOMustang Bio Inc. | 0.417 | -7.37% | $3.16M | vs SILO |
| MTNBMatinas Biopharma Holdings Inc. | 2.83 | +2.17% | $2.77M | vs SILO |
| KAPAKairos Pharma Ltd. | 0.9595 | +10.29% | $3.25M | vs SILO |
| APVOAptevo Therapeutics Inc. | 1.80 | -2.17% | $3.26M | vs SILO |
Indexes, lists and sector
Appears in lists
Silo Pharma stock FAQ
What is Silo Pharma's stock price today?
SILO last traded at $1.45 as of Oct 8, 4:00 PM EDT, up 0.69% on the day. Prices are delayed at least 15 minutes.
Who is Silo Pharma's CEO?
Mr. Eric Weisblum is the chief executive officer of Silo Pharma Inc., which has about 3 employees.
What is the SILO 52-week high?
The 52-week high for SILO is $10.44 and the 52-week low is $1.30. The stock is currently 86.1% below its high.